Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cobimetinib and Irinotecan Liposome.

Hospital pharmacy·2024
Same author

Pertuzumab, Trastuzumab, and Docetaxel for HER2-Positive Breast Cancer.

Hospital pharmacy·2024
Same author

Drug Monographs: Trabectedin and Trifluridine-Tipiracil.

Hospital pharmacy·2024
Same author

Evaluation of Erythropoietin Stimulating Agents (ESA) and Their Effect on Blood Optimization for Cardiac Surgery.

Journal of pharmacy practice·2020
Same author

Cancer Chemotherapy Update: Bevacizumab, Etoposide, and Cisplatin Regimen for Refractory Brain Metastases.

Hospital pharmacy·2017
Same author

Drug Monographs: Avelumab and Ribociclib.

Hospital pharmacy·2017

Related Experiment Video

Updated: Mar 3, 2026

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

18.3K

Idelalisib and Rituximab Regimen.

A Kacee Barnett, J Aubrey Waddell, Dominic A Solimando

    Hospital Pharmacy
    |April 26, 2017
    PubMed
    Summary

    This review covers essential aspects of cancer chemotherapy, including drug preparation, dispensing, and administration. It highlights the importance of pharmacists understanding complex regimens and toxic agents for treating malignant diseases.

    Area of Science:

    • Oncology Pharmacy
    • Pharmacology
    • Cancer Therapeutics

    Background:

    • Cancer chemotherapy involves complex regimens and highly toxic agents requiring specialized pharmacist knowledge.
    • Effective management of antineoplastic therapy is crucial for patient outcomes.

    Purpose of the Study:

    • To review key issues in the preparation, dispensing, and administration of antineoplastic therapy.
    • To discuss commercially available and investigational agents used in treating malignant diseases.

    Main Methods:

    • Review of published data and clinical expertise.
    • Inclusion of information beyond standard product labeling.

    Main Results:

    • Provides a comprehensive overview of antineoplastic therapy management.

    More Related Videos

    Phospho Flow Cytometry with Fluorescent Cell Barcoding for Single Cell Signaling Analysis and Biomarker Discovery
    08:38

    Phospho Flow Cytometry with Fluorescent Cell Barcoding for Single Cell Signaling Analysis and Biomarker Discovery

    Published on: October 4, 2018

    21.9K
    Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
    10:09

    Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

    Published on: January 7, 2019

    8.8K

    Related Experiment Videos

    Last Updated: Mar 3, 2026

    In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
    07:25

    In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

    Published on: May 4, 2017

    18.3K
    Phospho Flow Cytometry with Fluorescent Cell Barcoding for Single Cell Signaling Analysis and Biomarker Discovery
    08:38

    Phospho Flow Cytometry with Fluorescent Cell Barcoding for Single Cell Signaling Analysis and Biomarker Discovery

    Published on: October 4, 2018

    21.9K
    Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
    10:09

    Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

    Published on: January 7, 2019

    8.8K
  • Offers insights into off-label use of chemotherapy agents based on robust data.

    • Conclusions:

    • Pharmacists must be well-versed in chemotherapy complexities for safe and effective patient care.
    • Utilizing published data enhances the assessment of chemotherapy drugs and supports informed clinical decisions.